Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2007-05-23 11:20:02 UTC |
---|
Update Date | 2021-10-13 04:49:00 UTC |
---|
HMDB ID | HMDB0006483 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | D-Aspartic acid |
---|
Description | D-Aspartic acid is the D-isomer of aspartic acid. Since its discovery in invertebrates, free D-aspartate (D-Asp) has been identified in a variety of organisms, including microorganisms, plants, and lower animals, mammals and humans. D-Asp in mammalian tissues is present in specific cells, indicating the existence of specific molecular components that regulate D-Asp levels and localization in tissues. In the rat adrenal medulla, D-Asp is closely associated with adrenaline-cells (A-cells), which account for approximately 80% of the total number of chromaffin cells in the tissue, and which make and store adrenaline. D-Asp appears to be absent from noradrenaline-cells (NA-cells), which comprise approximately 20% of the total number of chromaffin cells in the adrenal medulla, and which make and store noradrenaline. D-aspartate oxidase (EC 1.4.3.1, D-AspO), which catalyzes oxidative deamination of D-Asp, appears to be present only in NA-cells, suggesting that the lack of D-Asp in these cells is due to D-Asp oxidase-mediated metabolism of D-Asp. In the rat adrenal cortex, the distribution of D-Asp changes during development. It has been suggested that developmental changes in the localization of D-Asp reflects the participation of D-Asp in the development and maturation of steroidogenesis in rat adrenal cortical cells. D-Asp is involved in steroid hormone synthesis and secretion in mammals as well. D-Asp is synthesized intracellularly, most likely by Asp racemase (EC 5.1.1.13). Endogenous D-Asp apparently has two different intracellular localization patterns: cytoplasmic and vesicular. D-Asp release can occur through three distinct pathways: 1) spontaneous, continuous release of cytoplasmic D-Asp, which is not associated with a specific stimulus; 2) release of cytoplasmic D-Asp via a volume-sensitive organic anion channel that connects the cytoplasm and extracellular space; 3) exocytotic discharge of vesicular D-Asp. D-Asp can be released via a mechanism that involves the L-Glu transporter. D-Asp is thus apparently in dynamic flux at the cellular level to carry out its physiological function(s) in mammals (PMID:16755369 ). |
---|
Structure | InChI=1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)/t2-/m1/s1 |
---|
Synonyms | Value | Source |
---|
(R)-2-Aminobutanedioic acid | ChEBI | (R)-2-Aminosuccinic acid | ChEBI | Aspartic acid D-form | ChEBI | D-Asparaginsaeure | ChEBI | DAS | ChEBI | (R)-2-Aminobutanedioate | Generator | (R)-2-Aminosuccinate | Generator | Aspartate D-form | Generator | D-Aspartate | Generator | D Aspartate | MeSH | D Aspartic acid | MeSH | (-)-Aspartic acid | HMDB | (2R)-2-Aminobutanedioate | HMDB | (2R)-2-Aminobutanedioic acid | HMDB | (R)-Aspartic acid | HMDB | 1-amino-1,2-Carboxyethane | HMDB | Aspartic acid | HMDB | D-(-)-Aspartic acid | HMDB | delta-(-)-Aspartic acid | HMDB | delta-Asparaginsaeure | HMDB | delta-Aspartate | HMDB | delta-Aspartic acid | HMDB | Lopac-alpha-9256 | HMDB | Tocris-0213 | HMDB |
|
---|
Chemical Formula | C4H7NO4 |
---|
Average Molecular Weight | 133.1027 |
---|
Monoisotopic Molecular Weight | 133.037507717 |
---|
IUPAC Name | (2R)-2-aminobutanedioic acid |
---|
Traditional Name | D-aspartic acid |
---|
CAS Registry Number | 1783-96-6 |
---|
SMILES | N[C@H](CC(O)=O)C(O)=O |
---|
InChI Identifier | InChI=1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)/t2-/m1/s1 |
---|
InChI Key | CKLJMWTZIZZHCS-UWTATZPHSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as aspartic acid and derivatives. Aspartic acid and derivatives are compounds containing an aspartic acid or a derivative thereof resulting from reaction of aspartic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Aspartic acid and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Aspartic acid or derivatives
- Alpha-amino acid
- D-alpha-amino acid
- Dicarboxylic acid or derivatives
- Fatty acid
- Amino acid
- Carboxylic acid
- Organic oxide
- Organopnictogen compound
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Primary aliphatic amine
- Organic oxygen compound
- Carbonyl group
- Amine
- Organic nitrogen compound
- Hydrocarbon derivative
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Not Available | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | |
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times UnderivatizedChromatographic Method | Retention Time | Reference |
---|
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 0.59 minutes | 32390414 | Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | -6.23 minutes | 32390414 | Predicted by Siyang on May 30, 2022 | 9.4032 minutes | 33406817 | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 8.51 minutes | 32390414 | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 418.0 seconds | 40023050 | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 481.9 seconds | 40023050 | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 355.8 seconds | 40023050 | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 37.7 seconds | 40023050 | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 231.7 seconds | 40023050 | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 106.0 seconds | 40023050 | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 299.4 seconds | 40023050 | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 222.5 seconds | 40023050 | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 897.8 seconds | 40023050 | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 587.7 seconds | 40023050 | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 41.4 seconds | 40023050 | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 693.9 seconds | 40023050 | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 223.3 seconds | 40023050 | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 352.4 seconds | 40023050 | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 730.1 seconds | 40023050 | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 503.6 seconds | 40023050 | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 484.2 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
D-Aspartic acid,1TMS,isomer #1 | C[Si](C)(C)OC(=O)C[C@@H](N)C(=O)O | 1393.4 | Semi standard non polar | 33892256 | D-Aspartic acid,1TMS,isomer #2 | C[Si](C)(C)OC(=O)[C@H](N)CC(=O)O | 1347.9 | Semi standard non polar | 33892256 | D-Aspartic acid,1TMS,isomer #3 | C[Si](C)(C)N[C@H](CC(=O)O)C(=O)O | 1412.7 | Semi standard non polar | 33892256 | D-Aspartic acid,2TMS,isomer #1 | C[Si](C)(C)OC(=O)C[C@@H](N)C(=O)O[Si](C)(C)C | 1413.6 | Semi standard non polar | 33892256 | D-Aspartic acid,2TMS,isomer #2 | C[Si](C)(C)N[C@H](CC(=O)O[Si](C)(C)C)C(=O)O | 1504.6 | Semi standard non polar | 33892256 | D-Aspartic acid,2TMS,isomer #3 | C[Si](C)(C)N[C@H](CC(=O)O)C(=O)O[Si](C)(C)C | 1457.1 | Semi standard non polar | 33892256 | D-Aspartic acid,2TMS,isomer #4 | C[Si](C)(C)N([C@H](CC(=O)O)C(=O)O)[Si](C)(C)C | 1619.8 | Semi standard non polar | 33892256 | D-Aspartic acid,3TMS,isomer #1 | C[Si](C)(C)N[C@H](CC(=O)O[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1548.8 | Semi standard non polar | 33892256 | D-Aspartic acid,3TMS,isomer #1 | C[Si](C)(C)N[C@H](CC(=O)O[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1566.3 | Standard non polar | 33892256 | D-Aspartic acid,3TMS,isomer #1 | C[Si](C)(C)N[C@H](CC(=O)O[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1715.5 | Standard polar | 33892256 | D-Aspartic acid,3TMS,isomer #2 | C[Si](C)(C)OC(=O)C[C@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1651.1 | Semi standard non polar | 33892256 | D-Aspartic acid,3TMS,isomer #2 | C[Si](C)(C)OC(=O)C[C@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1611.5 | Standard non polar | 33892256 | D-Aspartic acid,3TMS,isomer #2 | C[Si](C)(C)OC(=O)C[C@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1863.4 | Standard polar | 33892256 | D-Aspartic acid,3TMS,isomer #3 | C[Si](C)(C)OC(=O)[C@@H](CC(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1628.8 | Semi standard non polar | 33892256 | D-Aspartic acid,3TMS,isomer #3 | C[Si](C)(C)OC(=O)[C@@H](CC(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1614.9 | Standard non polar | 33892256 | D-Aspartic acid,3TMS,isomer #3 | C[Si](C)(C)OC(=O)[C@@H](CC(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1811.5 | Standard polar | 33892256 | D-Aspartic acid,4TMS,isomer #1 | C[Si](C)(C)OC(=O)C[C@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1707.3 | Semi standard non polar | 33892256 | D-Aspartic acid,4TMS,isomer #1 | C[Si](C)(C)OC(=O)C[C@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1680.4 | Standard non polar | 33892256 | D-Aspartic acid,4TMS,isomer #1 | C[Si](C)(C)OC(=O)C[C@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1664.0 | Standard polar | 33892256 | D-Aspartic acid,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C[C@@H](N)C(=O)O | 1626.3 | Semi standard non polar | 33892256 | D-Aspartic acid,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](N)CC(=O)O | 1598.8 | Semi standard non polar | 33892256 | D-Aspartic acid,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N[C@H](CC(=O)O)C(=O)O | 1672.0 | Semi standard non polar | 33892256 | D-Aspartic acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C[C@@H](N)C(=O)O[Si](C)(C)C(C)(C)C | 1857.9 | Semi standard non polar | 33892256 | D-Aspartic acid,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N[C@H](CC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O | 1937.4 | Semi standard non polar | 33892256 | D-Aspartic acid,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N[C@H](CC(=O)O)C(=O)O[Si](C)(C)C(C)(C)C | 1898.5 | Semi standard non polar | 33892256 | D-Aspartic acid,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)N([C@H](CC(=O)O)C(=O)O)[Si](C)(C)C(C)(C)C | 2057.2 | Semi standard non polar | 33892256 | D-Aspartic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N[C@H](CC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2153.5 | Semi standard non polar | 33892256 | D-Aspartic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N[C@H](CC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2162.8 | Standard non polar | 33892256 | D-Aspartic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N[C@H](CC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2113.0 | Standard polar | 33892256 | D-Aspartic acid,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)C[C@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2292.4 | Semi standard non polar | 33892256 | D-Aspartic acid,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)C[C@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2222.1 | Standard non polar | 33892256 | D-Aspartic acid,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)C[C@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2173.3 | Standard polar | 33892256 | D-Aspartic acid,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H](CC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2301.2 | Semi standard non polar | 33892256 | D-Aspartic acid,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H](CC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2201.8 | Standard non polar | 33892256 | D-Aspartic acid,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H](CC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2143.9 | Standard polar | 33892256 | D-Aspartic acid,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C[C@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2544.7 | Semi standard non polar | 33892256 | D-Aspartic acid,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C[C@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2441.4 | Standard non polar | 33892256 | D-Aspartic acid,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C[C@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2169.3 | Standard polar | 33892256 |
|
---|
Disease References | Schizophrenia |
---|
- Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25. [PubMed:22024767 ]
| Irritable bowel syndrome |
---|
- Ponnusamy K, Choi JN, Kim J, Lee SY, Lee CH: Microbial community and metabolomic comparison of irritable bowel syndrome faeces. J Med Microbiol. 2011 Jun;60(Pt 6):817-27. doi: 10.1099/jmm.0.028126-0. Epub 2011 Feb 17. [PubMed:21330412 ]
| Crohn's disease |
---|
- Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson ID, Wang Y: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007 Feb;6(2):546-51. [PubMed:17269711 ]
| Colorectal cancer |
---|
- Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP: Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One. 2013 Aug 6;8(8):e70803. doi: 10.1371/journal.pone.0070803. Print 2013. [PubMed:23940645 ]
| Autism |
---|
- De Angelis M, Piccolo M, Vannini L, Siragusa S, De Giacomo A, Serrazzanetti DI, Cristofori F, Guerzoni ME, Gobbetti M, Francavilla R: Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One. 2013 Oct 9;8(10):e76993. doi: 10.1371/journal.pone.0076993. eCollection 2013. [PubMed:24130822 ]
|
|
---|
General References | - Homma H: Biochemistry of D-aspartate in mammalian cells. Amino Acids. 2007 Jan;32(1):3-11. Epub 2006 Jun 7. [PubMed:16755369 ]
- Brunk E, Sahoo S, Zielinski DC, Altunkaya A, Drager A, Mih N, Gatto F, Nilsson A, Preciat Gonzalez GA, Aurich MK, Prlic A, Sastry A, Danielsdottir AD, Heinken A, Noronha A, Rose PW, Burley SK, Fleming RMT, Nielsen J, Thiele I, Palsson BO: Recon3D enables a three-dimensional view of gene variation in human metabolism. Nat Biotechnol. 2018 Mar;36(3):272-281. doi: 10.1038/nbt.4072. Epub 2018 Feb 19. [PubMed:29457794 ]
|
---|